Claims
- 1. A method for forming a mutagenized DNA molecule encoding an enzyme having protox activity from at least two non-identical template DNA molecules encoding enzymes having protox activity, said method comprising the steps of:a) adding to the template DNA molecules at least one oligonucleotide comprising an area of identity to each of the template DNA molecule; b) denaturing the resultant mixture into single-stranded molecules; c) incubating the resultant population of single-stranded molecules with a polymerase under conditions that result in the annealing of the oligonucleotides to the template DNA molecules, wherein the conditions for polymerization by the polymerase are such that polymerization products corresponding to a portion of the template DNA molecules are obtained; d) repeating the second and third steps for at least two further cycles, wherein the extension products obtained in step c) are able to switch template DNA molecule for polymerization in the next cycle, thereby forming a mutagenized double-stranded polynucleotide comprising sequences derived from different template DNA molecules; wherein the mutagenized double-stranded polynucleotide encodes a protox enzyme having enhanced tolerance to a herbicide that inhibits the protox activity encoded by the template DNA molecules.
- 2. The method of claim 1, wherein at least one template DNA molecule is derived from a eukaryote.
- 3. The method of claim 2, wherein said eukaryote is a higher eukaryote.
- 4. The method of claim 3, wherein said higher eukaryote is a plant.
- 5. The method of claim 3, wherein said plant is selected from the group consisting of Arabidopsis thaliana, oilseed rape, soybean, sugarbeet, cotton, maize, wheat, rice, sugarcane, and sorghum.
- 6. The method of claim 3, wherein at least one said template DNA molecule derived from said plant comprises at least one mutation and encodes a modified protoporphyrinogen oxidase (protox) having at least one amino acid modification, wherein said modified protox is tolerant to a herbicide in amounts that inhibit said protox.
- 7. The method of claim 6, wherein at least one said template DNA molecule is further characterized in that at least one of the following conditions is met:(a) said template DNA molecule has a sequence that encodes amino acid sub-sequence APΔ1F, wherein Δ1 is an amino acid other than arginine; (b) said template DNA molecule has a sequence that encodes amino acid sub-sequence FΔ2S, wherein Δ2 is an amino acid other than cysteine; (c) said template DNA molecule has a sequence that encodes amino acid sub-sequence YΔ3G, wherein Δ3 is an amino acid other than alanine; (d) said template DNA molecule has a sequence that encodes amino acid sub-sequence AΔ4D, wherein Δ4 is an amino acid other than glycine; (e) said template DNA molecule has a sequence that encodes amino acid sub-sequence YΔ5P, wherein Δ5 is an amino acid other than proline; (f) said template DNA molecule has a sequence that encodes amino acid sub-sequence PΔ6A, wherein Δ6 is an amino acid other than valine; (g) said template DNA molecule has a sequence that encodes amino acid sub-sequence Δ7G, wherein Δ7 is an amino acid other than tyrosine; (h) said template DNA molecule has a sequence that encodes amino acid sub-sequence YIGGΔ8, wherein Δ8 is an amino acid other than alanine or serine; (i) said template DNA molecule has a sequence that encodes amino acid sub-sequence AΔ9P, wherein Δ9 is an amino acid other than isoleucine; (j) said template DNA molecule has a sequence that encodes amino acid sub-sequence GΔ10A, wherein Δ10 is an amino acid other than valine; (k) said template DNA molecule has a sequence that encodes amino acid sub-sequence YΔ3G, wherein Δ3 is an amino acid other than alanine, and said template DNA molecule also has a sequence that encodes one of the group consisting of: (1) sub-sequence QΔ11S, wherein Δ11 is an amino acid other than proline, (2) sub-sequence IGGΔ12, wherein Δ12 is an amino acid other than threonine, (3) sub-sequence SWXLΔ13, wherein Δ13 is an amino acid other than serine, (4) sub-sequence LΔ14Y, wherein Δ14 is an amino acid other than asparagine, and (5) sub-sequence GΔ15XGL, wherein Δ15 is an amino acid other than tyrosine; (l) said template DNA molecule has a sequence that encodes amino acid sub-sequence Δ7G, wherein Δ7 is an amino acid other than tyrosine, and said template DNA molecule also has a sequence that encodes one of the group consisting of: (1) sub-sequence QΔ11S, wherein Δ11 is an amino acid other than proline, (2) sub-sequence IGGΔ12, wherein Δ12 is an amino acid other than threonine, (3) sub-sequence SWXLΔ13, wherein Δ13 is an amino acid other than serine, (4) sub-sequence LΔ14Y, wherein Δ14 is an amino acid other than asparagine, and (5) sub-sequence GΔ15XGL, wherein Δ15 is an amino acid other than tyrosine; and (m) said template DNA molecule has a sequence that encodes amino acid sub-sequence TΔ16G, wherein Δ16 is an amino acid other than leucine, and said template DNA molecule also has a sequence that encodes amino acid sub-sequence YVΔ17G, wherein Δ16 is an amino acid other than alanine.
- 8. The method of claim 1, wherein at least one said template DNA molecule is derived from a prokaryote.
- 9. The method of claim 1, wherein said herbicide is selected from the group consisting of an aryluracil, a diphenylether, an oxidiazole, an imide, a phenyl pyrazole, a pyridyl pyrazole, a pyridine derivative, a 3-substituted-2-aryl-4,5,6,7-tetrahydroindazole, a phenopylate and O-phenylpyrrolidino- and piperidinocarbamate analogs of said phenopylate.
Parent Case Info
This application is a division of U.S. application Ser. No. 09/102,419, filed Jun. 22, 1998, abandoned, which is a continuation-in-part of U.S. application Ser. No. 09/059,164, filed Apr. 13, 1998, abandoned, which is a continuation-in-part of U.S. application Ser. No. 09/050,603, filed Mar. 30, 1998, now U.S. Pat. No. 6,023,012, issued Feb. 8, 2000, which is a continuation-in-part of U.S. application Ser. No. 08/808,931, filed Feb. 28, 1997, now U.S. Pat. No. 5,939,602, issued Aug. 17, 1999, which is a continuation-in-part of U.S. application Ser. No. 08/472,028, filed Jun. 6, 1995, now U.S. Pat. No. 5,767,373, issued Jun. 16, 1998, which is a continuation-in-part of U.S. application Ser. No. 08/261,198, filed Jun. 16, 1994, now abandoned. Said U.S. application Ser. No. 08/808,931 also claims the benefit of U.S. Provisional Application No. 60/012,705, filed Feb. 28, 1996, U.S. Provisional Application No. 60/013,612, filed Feb. 28, 1996, and U.S. Provisional Application No. 60/020,003, filed Jun. 21, 1996. Said U.S. application Ser. No. 09/059,164 also claims the benefit of U.S. Provisional Application No: 60/126,430 filed Mar. 11, 1998. All of the aforementioned applications are incorporated herein by reference.
US Referenced Citations (16)
Foreign Referenced Citations (2)
Number |
Date |
Country |
WO9720078 |
Jun 1997 |
WO |
WO9805765 |
Feb 1998 |
WO |
Non-Patent Literature Citations (3)
Entry |
Stemmer et al., Nature, 370: 389-391 (1994). |
Crameri et al., Nature, 391: 288-291 (1998). |
Zhao et al., Nature Biotechnology, 16: 258-261 (1998). |
Provisional Applications (4)
|
Number |
Date |
Country |
|
60/126430 |
Mar 1998 |
US |
|
60/020003 |
Jun 1996 |
US |
|
60/013612 |
Feb 1996 |
US |
|
60/012705 |
Feb 1996 |
US |
Continuation in Parts (5)
|
Number |
Date |
Country |
Parent |
09/059164 |
Apr 1998 |
US |
Child |
09/102419 |
|
US |
Parent |
09/050603 |
Mar 1998 |
US |
Child |
09/059164 |
|
US |
Parent |
08/808931 |
Feb 1997 |
US |
Child |
09/050603 |
|
US |
Parent |
08/472028 |
Jun 1995 |
US |
Child |
08/808931 |
|
US |
Parent |
08/261198 |
Jun 1994 |
US |
Child |
08/472028 |
|
US |